EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis

Shuyue Tuo, Yee Hui Yeo, Rachel Chang, Zhang Wen, Qiuju Ran, Longbao Yang, Qing Fan, Junxiu Kang, Jiaojiao Si, Yi Liu, Haitao Shi, Yong Li und 7 weitere

Clinical Nutrition · 2024-01 · 43 (1) · 84-94

DOI: 10.1016/j.clnu.2023.11.008 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Nutrition, 2024-01. Verfasst von Shuyue Tuo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sarcopenia is associated with poor outcomes in patients with cirrhosis. However, the prevalence of and associated factors for developing sarcopenia in this population remain to be determined. OBJECTIVES: This study aimed to summarize the prevalence, characteristics, and associated factors of sarcopenia in patients with cirrhosis. METHODS: Electronic searches were performed from inception to June 9, 2022 to identify the eligible studies. We meta-analyzed the prevalence of sarcopenia in overall patients with cirrhosis and subgroups. Both crude and adjusted odds ratios (ORs) were pooled using the random effects model. RESULTS: A total of 55 studies involving 13,158 patients from 17 countries were included. The overall prevalence of sarcopenia was 40.1 % (95 % CI 35.4%-44.9 %) in patients with cirrhosis. The pooled prevalence was higher in males, Child-Pugh class C cirrhosis, decompensated stage, ascites, subjective global assessment class C cirrhosis, and when sarcopenia was defined by L3-SMI (third lumbar-skeletal muscle index) at a higher cutoff. In multivariate analysis, older age (adjusted OR 1.04, 95 % CI 1.00-1.07), male (adjusted OR 4.75, 95 % CI 2.72-8.28), lower body mass index (BMI) (adjusted OR 0.78, 95 % CI 0.73-0.83), alcoholic liver disease (ALD) (adjusted OR 1.43, 95 % CI 1.19-1.72), but not ascites and hepatic encephalopathy, were significantly associated with an increased risk of sarcopenia in patients with cirrhosis. CONCLUSION: Sarcopenia is a prevalent complication, and older age, male patients, lower BMI, and patients with ALD are associated with an increased risk of sarcopenia in patients with cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaHumansMalePrevalenceLiver CirrhosisMuscle, SkeletalFibrosisAscites

Stichwörter der Autor:innen

Associated factorsCirrhosisMeta-analysisPrevalenceSarcopeniaSystematic review

Autor:innen und Institutionen

  • Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Internal Medicine, Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD, USA.
  • Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; Clinical Research Center for Gastrointestinal Diseases of Shaanxi Province, The Second Affiliated Hospi…
  • Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affili…

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Tuo, S., Yeo, Y. H., Chang, R., Wen, Z., Ran, Q., Yang, L., Fan, Q., Kang, J., Si, J., Liu, Y., Shi, H., Li, Y., Yuan, J., Liu, N., Dai, S., Guo, X., Wang, J., Ji, F., & Tantai, X. (2024). Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. Clinical Nutrition, 43(1), 84-94. https://doi.org/10.1016/j.clnu.2023.11.008

Vancouver

Tuo S, Yeo YH, Chang R, Wen Z, Ran Q, Yang L, et al. Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. Clinical Nutrition. 2024;43(1):84-94. doi:10.1016/j.clnu.2023.11.008

BibTeX
@article{Tuo2024,
  author = {Tuo, Shuyue and Yeo, Yee Hui and Chang, Rachel and Wen, Zhang and Ran, Qiuju and Yang, Longbao and Fan, Qing and Kang, Junxiu and Si, Jiaojiao and Liu, Yi and Shi, Haitao and Li, Yong and Yuan, Jia and Liu, Na and Dai, Shejiao and Guo, Xiaoyan and Wang, Jinhai and Ji, Fanpu and Tantai, Xinxing},
  title = {Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis},
  journal = {Clinical Nutrition},
  year = {2024},
  volume = {43},
  number = {1},
  pages = {84--94},
  doi = {10.1016/j.clnu.2023.11.008}
}
Kostenlos starten →